T. Rowe Price Investment Management, Inc.

Holdings History for AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Symbol: AVNS on NYSE
Investment type: Equity / Common Stock - $0.01 Par Value
Latest Disclosed Shares Owned: 4,713,494 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Investment Management, Inc. ownership in AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS)

07 Oct 2025 - T. Rowe Price Investment Management, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,713,494 shares of AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS). This represents 10% ownership of the company. In their previous filing dated 14 May 2025, T. Rowe Price Investment Management, Inc. had reported owning 3,757,576 shares, indicating an increase of +25%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
T. Rowe Price Investment Management, Inc.	10%	+25%	$54,487,048	4,713,494	+955,918	+25%	$11.56	13G/A	30 Sep 2025	07 Oct 2025, 12:51
T. Rowe Price Investment Management, Inc.	8.2%	+23%	$46,406,064	3,757,576	+746,264	+25%	$12.35	13G/A	31 Mar 2025	14 May 2025, 10:47
T. Rowe Price Investment Management, Inc.	6.6%		$37,189,703	3,011,312			$12.35	13G/A	31 Dec 2024	14 Feb 2025, 09:45

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	-0%	$50,206,000	4,470,622	-242,872	-5.2%	$11.23	Q4 2025
30 Sep 2025	0.03%	+0.01%	$54,488,000	4,713,494	+716,976	+18%	$11.56	Q3 2025
30 Jun 2025	0.03%	+0%	$48,918,000	3,996,518	+238,942	+6.4%	$12.24	Q2 2025
31 Mar 2025	0.04%	+0.01%	$53,847,000	3,757,576	+746,264		$14.33	Q1 2025
31 Dec 2024	0.03%	+0.01%	$47,941,000	3,011,312	+644,267	+27%	$15.92	Q4 2024
30 Sep 2024	0.03%	+0%	$56,881,000	2,367,045	+149,252	+6.7%	$24.03	Q3 2024
30 Jun 2024	0.03%	+0%	$44,179,000	2,217,793	+291,026	+15%	$19.92	Q2 2024
31 Mar 2024	0.02%	+0%	$38,362,000	1,926,767	+70,899	+3.8%	$19.91	Q1 2024
31 Dec 2023	0.03%	+0%	$41,628,000	1,855,868	+228,785	+14%	$22.43	Q4 2023
30 Sep 2023	0.02%	+0%	$32,900,000	1,627,083	+117,901	+7.8%	$20.22	Q3 2023
30 Jun 2023	0.03%	+0%	$38,575,000	1,509,182	+270,471	+22%	$25.56	Q2 2023
31 Mar 2023	0.03%	+0.03%	$36,840,000	1,238,711	+1,238,711	NEW	$29.74	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.